Praxis Investment Management Inc. Purchases 650 Shares of Align Technology, Inc. $ALGN

Praxis Investment Management Inc. lifted its position in Align Technology, Inc. (NASDAQ:ALGN) by 41.4% in the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,220 shares of the medical equipment provider’s stock after acquiring an additional 650 shares during the period. Praxis Investment Management Inc.’s holdings in Align Technology were worth $420,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Cromwell Holdings LLC raised its position in shares of Align Technology by 2,900.0% in the 2nd quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock worth $34,000 after acquiring an additional 174 shares in the last quarter. Center for Financial Planning Inc. bought a new position in Align Technology during the 1st quarter valued at approximately $35,000. SVB Wealth LLC bought a new position in Align Technology during the 1st quarter valued at approximately $36,000. Farther Finance Advisors LLC increased its position in Align Technology by 42.2% during the 2nd quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider’s stock valued at $59,000 after buying an additional 92 shares in the last quarter. Finally, Mather Group LLC. increased its position in Align Technology by 375.0% during the 1st quarter. Mather Group LLC. now owns 437 shares of the medical equipment provider’s stock valued at $69,000 after buying an additional 345 shares in the last quarter. Institutional investors own 88.43% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on ALGN shares. UBS Group reduced their price objective on Align Technology from $160.00 to $155.00 and set a “neutral” rating for the company in a research report on Thursday. Wells Fargo & Company reduced their price objective on Align Technology from $246.00 to $199.00 and set an “overweight” rating for the company in a research report on Thursday, July 31st. Leerink Partners reduced their price objective on Align Technology from $188.00 to $172.00 and set an “outperform” rating for the company in a research report on Tuesday, October 14th. Stifel Nicolaus reduced their price objective on Align Technology from $275.00 to $200.00 and set a “buy” rating for the company in a research report on Thursday, July 31st. Finally, Piper Sandler reduced their price objective on Align Technology from $250.00 to $190.00 and set an “overweight” rating for the company in a research report on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, seven have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, Align Technology has a consensus rating of “Hold” and an average target price of $182.67.

Insider Activity

In other news, CEO Joseph M. Hogan purchased 7,576 shares of the company’s stock in a transaction dated Friday, August 1st. The shares were purchased at an average cost of $131.49 per share, for a total transaction of $996,168.24. Following the purchase, the chief executive officer directly owned 184,945 shares in the company, valued at approximately $24,318,418.05. This represents a 4.27% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.66% of the stock is currently owned by company insiders.

Align Technology Price Performance

Align Technology stock opened at $130.45 on Friday. Align Technology, Inc. has a one year low of $122.00 and a one year high of $246.19. The stock has a market capitalization of $9.46 billion, a PE ratio of 22.00, a price-to-earnings-growth ratio of 1.48 and a beta of 1.70. The business’s fifty day moving average is $134.71 and its 200 day moving average is $163.30.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 EPS for the quarter, missing the consensus estimate of $2.57 by ($0.08). Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The business had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1.06 billion. During the same period last year, the business earned $2.41 earnings per share. The company’s quarterly revenue was down 1.6% on a year-over-year basis. Align Technology has set its Q3 2025 guidance at EPS. As a group, sell-side analysts expect that Align Technology, Inc. will post 7.98 EPS for the current fiscal year.

Align Technology declared that its board has initiated a share buyback program on Tuesday, August 5th that permits the company to repurchase $200.00 million in outstanding shares. This repurchase authorization permits the medical equipment provider to purchase up to 2% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board of directors believes its stock is undervalued.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.